Press Releases
Conferences & Exhibitions

PBS Biotech® Launches Single-Use Bioreactor for Development of New Vaccines and Biosimilars

Benchtop size, plug and play bioreactor in tandem with the low profile
and high performance ATF™ System on display at ESACT in Vienna
Camarillo, California, May 11, 2011 – PBS Biotech, Inc., a developer of state of the art single-use bioreactors used in the fast growing biotechnology market, announced today it has partnered with Refine Technology, Pine Brook, New Jersey to provide a powerful perfusion application providing high cell density solutions for biotech customers. The PBS 15 liter single-use bioreactor and the Refine Technology ATF4 system will be on display at the ESACT conference May 15-18 in Vienna.PBS Biotech® and Refine Technology, two technology leaders in cell culture development, are the ideal pair for biotech lab to production perfusion applications. Boasting low profile, high performance and easy to use systems, the PBS Biotech 15L and PBS 80L single-use bioreactors can be configured with the Refine Technology ATF4 System and ATF6 System, respectively.
PBS bioreactors feature low shear mixing and high mass transfer rates from the patented Air Wheel™ mixing mechanism, making them a perfect complement to the Refine Technology ATF™ System which provides a reliable and efficient process of cell separation and supports cell growth to extreme concentrations. The ATF System allows increased volumetric productivity and reduced bioreactor size. Together the PBS Biotech single-use bioreactors and the Refine Technology perfusion systems are ideal for demanding R&D laboratory to clinical stage high-density cell culture applications including:

  • Concentrated perfusion
  • Concentrated fed batch
  • Continuous culture
  • Primary recovery/clarification
Key Benefits of the PBS/Refine Technology Solution:

  • Significantly increased cell density
  • Simpler cell separation
  • Low profile, ease of use and high performance
  • Reduced equipment costs
  • Reduce vaccine and protein development and production costs
  • Increase operational flexibility and process efficiency

About PBS Biotech

PBS Biotech, Inc. is a U.S. corporation headquartered in Camarillo, California that manufactures fully scalable and easy-to-use single-use bioreactors for global biotechnology organizations. The company has developed innovative, efficient, and scalable bioreactors by combining a patented pneumatic mixing mechanism with an advanced, proprietary control system. This novel bioreactor solution offers improved operational efficiency and flexibility with reduced costs and ultimately shorter time to market for biotechnology customers. PBS Biotech is poised for rapid growth by supporting industry demand for single-use technologies.

About Refine Technology

Refine Technology was founded in 1999 with a vision to bring to the biopharmaceutical market cell separation systems that allow for increased productivity of cell derived biopharmaceuticals. Refine soon introduced its patented ATF System which is now being used in the development and manufacturing facilities of many biological and pharmaceutical companies.


PBS Biotech® Contact: Rick Sullivan, VP Sales & Marketing
+1 435-757-3198
www.pbsbiotech.com


Refine Technology Contact: John Bonham-Carter, VP – Sales & Business Development
+1 (732) 993-3003 and EU +46 76 256 5114
www.refinetech.com